+

US20020156393A1 - Device and procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming - Google Patents

Device and procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming Download PDF

Info

Publication number
US20020156393A1
US20020156393A1 US10/112,600 US11260002A US2002156393A1 US 20020156393 A1 US20020156393 A1 US 20020156393A1 US 11260002 A US11260002 A US 11260002A US 2002156393 A1 US2002156393 A1 US 2002156393A1
Authority
US
United States
Prior art keywords
intra
extent
abdominal
abdominal fat
pole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US10/112,600
Other versions
US6889076B2 (en
Inventor
Valerio Cigaina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Transneuronix Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of US20020156393A1 publication Critical patent/US20020156393A1/en
Assigned to TRANSNEURONIX, INC. reassignment TRANSNEURONIX, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CIGAINA, VALERIO
Application granted granted Critical
Publication of US6889076B2 publication Critical patent/US6889076B2/en
Adjusted expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4869Determining body composition
    • A61B5/4872Body fat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0537Measuring body composition by impedance, e.g. tissue hydration or fat content
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0538Measuring electrical impedance or conductance of a portion of the body invasively, e.g. using a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/42Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
    • A61B5/4222Evaluating particular parts, e.g. particular organs
    • A61B5/4238Evaluating particular parts, e.g. particular organs stomach

Definitions

  • the present invention relates to a device and a procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming.
  • the control of intra-abdominal fat extent in the monitoring of slimming after a bariatric surgical procedure or an implant of a gastric stimulator (pacemaker) is based on empirical, radiological or ultrasound procedures.
  • the technical object at the basis of the present invention is that of eliminating the technical disadvantages of the prior art, by providing a device and a method for controlling the extent of intra-abdominal fat that should allow measuring the intra-abdominal fat extent at a very high rate and that should thereby allow keeping the progressive slimming of the patient under control.
  • Such measurements allow tracing the curve of intra-abdominal fat loss, useful for obtaining prognostic information on the patient's health.
  • a purpose of the invention is to realise a device and a procedure for controlling the extent of intra-abdominal fat which should not require complex structures, such as radiological and ultrasound ones.
  • Last but not least, another purpose of the invention is to realise a device and a procedure for controlling the extent of intra-abdominal fat which should not have harmful effects on the patient even when carried out in a high number.
  • a device for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming characterised in that it comprises at least one electrical signal generator connected to at least one first pole, associable to the stomach surface, and a second pole, associable to the abdominal wall, said poles being connected to detection means and means for processing said electrical signals, intended to provide a signal indicating the extent of intra-abdominal fat.
  • the second pole is associable to the electrical signal generator box, or pacemaker, arranged on the outside of the abdominal wall.
  • the electrical circuit is closed by the tissue between the first and the second pole which, in an obese individual, exhibits a considerable component of intra-abdominal fat.
  • the impedance analysis upon the passage of an electrical pulse in this circuit provides an indicative value of the extent of intra-abdominal fat.
  • the invention also relates to a procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming, characterised in that the impedance of abdominal fat tissues is measured, and hence the extent of intra-abdominal fat is obtained.
  • impedance is measured between the two poles of an electrical circuit.
  • the device and the procedure can comprise elements such as electro-catheter and stimulator (pacemaker) that have been implanted in the patient for treating obesity and stomach motor disorders.
  • pacemaker stimulator
  • FIG. 1 shows a schematic view of a device according to the finding, applied to a patient
  • FIG. 2 shows a schematic section of a device according to the finding applied to a patient.
  • Device 1 comprises an electrical signal generator 2 connected to at least one first pole 3 associable to the stomach surface, and a second pole 4 , associable to the abdominal wall in super-fascial position.
  • Pole 3 is component of an electro-catheter 5
  • pole 4 in a first example consists of a portion of the signal generator, whereas in a further example is component of electro-catheter 5 .
  • poles 3 and 4 are arranged at opposed sides of the intra-abdominal adipose layer that must be controlled (to check the extent of intra-abdominal fat).
  • the two poles 3 and 4 are reciprocally connected through detection means 6 and means for processing electrical signals 7 intended to provide an indicative signal of the extent of intra-abdominal fat.
  • the detection means 6 comprises, for example, a wand or a knob of electromagnetic signals
  • the means for processing electrical signals 7 comprises a laptop or computer (electronic processor).
  • Wand 6 is connected to laptop 7 for communicating with a microchip of the signal generator or pacemaker, and the laptop supports a suitable program for managing communication with the access to the data being measured.
  • the electrical signal generator 2 is intended to generate pulse signals (pacemaker).
  • the second pole 4 comprises at least one portion of the electrical signal generator or pacemaker 2 and the first pole 3 comprises an electrode of electro-catheter 5 .
  • the electrical signal generator 2 (pacemaker) and electro-catheter 5 can be the same used for the electrical stimulation of the stomach, thereby no further surgical intervention is needed besides that for implanting the gastric pacemaker 2 for treating obesity and the motor disorders of the stomach.
  • Device 1 realised according to this embodiment is especially suitable to be implanted for measuring the extent of intra-abdominal fat after an implantation of a gastric electro-catheter connected to an electrical signal generator.
  • the second pole 4 comprises an outside subcutaneous detector and the first pole 3 comprises at least one electrode of electro-catheter 5 .
  • Device 1 realised according to this embodiment is especially suitable to be implanted for controlling the extent of fat after a bariatric surgery for treating obesity.
  • the detection means 6 of device 1 is intended to measure the impedance of abdominal fat tissues
  • the processing means 7 is intended to indicate the extent of intra-abdominal fat.
  • the detection means 6 is intended to detect the tension (potential different) between abdominal tissues when the same are crossed by a predetermined current.
  • the operation is based on the principle that biological tissues exhibit a certain impedance upon the passage of electrical current, which varies according to the extent of the different proportions between lean mass, adipose tissue and liquids of which they are composed.
  • stimulator 2 when stimulator 2 generates an electrical signal, it circulates in the electro-catheter 5 up to the first pole 3 , crosses the tissue containing also the adipose component (of course predominant in obese individuals) and reaches the second pole 4 .
  • a dedicated software stores the obtained values to the signal generator or pacemaker memory, and provides a graph on a fixed number of months.
  • the query-programming of the signal generator or pacemaker occurs through electromagnetic pulses provided by an outside WAND.
  • the processing means is capable of obtaining the extent of endo-abdominal fat since, as known, the biological tissue exhibits a given impedance upon the passage of an electrical current, which varies according to the different extent of fat contained therein.
  • the present finding also relates to a procedure for controlling the extent of intra-abdominal fat.
  • the procedure according to the finding consists in measuring the impedance of abdominal adipose tissues and hence, obtaining the extent of intra-abdominal fat.
  • Impedance is measured by making a predetermined current pass through the abdominal tissues and measuring the tension between abdominal tissues.
  • impedance is measured between the stomach surface and the abdomen wall.
  • the procedure provides for the preliminary application of an electrical signal generator 2 (pacemaker) in super-fascial position.
  • an electrical signal generator 2 pacemaker
  • the device and procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming according to the invention are especially advantageous since they allow tracing a curve of endo-abdominal fat loss, which has a considerable prognostic importance on the patient's health.
  • the materials used as well as the sizes can be of any type according to the needs and to the state of the art.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Electrotherapy Devices (AREA)
  • Endoscopes (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

The device (1) for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming, comprises one electrical signal generator (2) connected to at least one first pole (3), associable to the stomach surface, and a second pole (4), associable to the abdominal wall. The poles (3,4) are connected to detection means (6) and means (7) for processing said electrical signals, adapted to provide a signal indicating the extent of intra-abdominal fat. The control procedure of the entity of the intra-abdominal fat in the monitoring of an individual's slimming, consists in detecting the impedance of the abdominal fat tissues, and hence, in calculating the extent of intra-abdominal fat is obtained.

Description

    DESCRIPTION
  • The present invention relates to a device and a procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming. [0001]
  • The measurement of intra-abdominal fat extent has an important prognostic value on the patient's health, since obesity causes several and frequent vascular conditions. [0002]
  • At present, the control of intra-abdominal fat extent in the monitoring of slimming after a bariatric surgical procedure or an implant of a gastric stimulator (pacemaker) is based on empirical, radiological or ultrasound procedures. [0003]
  • However, the information regarding the intra-abdominal fat extent obtained by traditional methods does not allow frequent checks. Thereby, it does not allow keeping the progressive patient's slimming under control. [0004]
  • Moreover, the control of the intra-abdominal fat extent according to traditional procedures, requires complex structures (in particular radiological ones, but also ultrasound ones) and in some cases, traditional control operations must be necessarily carried out in a very restricted number due to the possible harmful effects for the patient (in particular with radiological methods). [0005]
  • The technical object at the basis of the present invention is that of eliminating the technical disadvantages of the prior art, by providing a device and a method for controlling the extent of intra-abdominal fat that should allow measuring the intra-abdominal fat extent at a very high rate and that should thereby allow keeping the progressive slimming of the patient under control. [0006]
  • Such measurements, carried out at a high frequency and regularly over time, allow tracing the curve of intra-abdominal fat loss, useful for obtaining prognostic information on the patient's health. [0007]
  • Within the scope of this technical object, a purpose of the invention is to realise a device and a procedure for controlling the extent of intra-abdominal fat which should not require complex structures, such as radiological and ultrasound ones. [0008]
  • Last but not least, another purpose of the invention is to realise a device and a procedure for controlling the extent of intra-abdominal fat which should not have harmful effects on the patient even when carried out in a high number. [0009]
  • The technical object, as well as these and other purposes, according to the present invention are achieved by realising a device for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming, characterised in that it comprises at least one electrical signal generator connected to at least one first pole, associable to the stomach surface, and a second pole, associable to the abdominal wall, said poles being connected to detection means and means for processing said electrical signals, intended to provide a signal indicating the extent of intra-abdominal fat. [0010]
  • Advantageously, the second pole is associable to the electrical signal generator box, or pacemaker, arranged on the outside of the abdominal wall. [0011]
  • The electrical circuit is closed by the tissue between the first and the second pole which, in an obese individual, exhibits a considerable component of intra-abdominal fat. [0012]
  • Therefore, the impedance analysis upon the passage of an electrical pulse in this circuit provides an indicative value of the extent of intra-abdominal fat. [0013]
  • The invention also relates to a procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming, characterised in that the impedance of abdominal fat tissues is measured, and hence the extent of intra-abdominal fat is obtained. [0014]
  • Advantageously, impedance is measured between the two poles of an electrical circuit. [0015]
  • Further features of the present invention are defined, moreover, in the other claims. [0016]
  • Advantageously, the device and the procedure can comprise elements such as electro-catheter and stimulator (pacemaker) that have been implanted in the patient for treating obesity and stomach motor disorders.[0017]
  • Further features and advantages of the invention will appear more clearly from the description of a preferred but non-exclusive embodiment of the device and procedure for controlling the extent of intra-abdominal fat according to the finding, where the device is illustrated by way of a non-limiting example in the attached drawings. In such drawings: [0018]
  • FIG. 1 shows a schematic view of a device according to the finding, applied to a patient; and [0019]
  • FIG. 2 shows a schematic section of a device according to the finding applied to a patient.[0020]
  • With reference to the above figures, there is shown a device for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming, globally indicated with [0021] reference numeral 1.
  • [0022] Device 1 comprises an electrical signal generator 2 connected to at least one first pole 3 associable to the stomach surface, and a second pole 4, associable to the abdominal wall in super-fascial position.
  • Pole [0023] 3 is component of an electro-catheter 5, whereas pole 4 in a first example consists of a portion of the signal generator, whereas in a further example is component of electro-catheter 5.
  • In the practice, [0024] poles 3 and 4 are arranged at opposed sides of the intra-abdominal adipose layer that must be controlled (to check the extent of intra-abdominal fat).
  • The two [0025] poles 3 and 4 are reciprocally connected through detection means 6 and means for processing electrical signals 7 intended to provide an indicative signal of the extent of intra-abdominal fat.
  • The detection means [0026] 6 comprises, for example, a wand or a knob of electromagnetic signals, and the means for processing electrical signals 7 comprises a laptop or computer (electronic processor).
  • [0027] Wand 6 is connected to laptop 7 for communicating with a microchip of the signal generator or pacemaker, and the laptop supports a suitable program for managing communication with the access to the data being measured.
  • Advantageously, the [0028] electrical signal generator 2 is intended to generate pulse signals (pacemaker).
  • In a first embodiment, the [0029] second pole 4 comprises at least one portion of the electrical signal generator or pacemaker 2 and the first pole 3 comprises an electrode of electro-catheter 5.
  • The electrical signal generator [0030] 2 (pacemaker) and electro-catheter 5 can be the same used for the electrical stimulation of the stomach, thereby no further surgical intervention is needed besides that for implanting the gastric pacemaker 2 for treating obesity and the motor disorders of the stomach.
  • [0031] Device 1 realised according to this embodiment is especially suitable to be implanted for measuring the extent of intra-abdominal fat after an implantation of a gastric electro-catheter connected to an electrical signal generator.
  • In a different embodiment, the [0032] second pole 4 comprises an outside subcutaneous detector and the first pole 3 comprises at least one electrode of electro-catheter 5.
  • [0033] Device 1 realised according to this embodiment is especially suitable to be implanted for controlling the extent of fat after a bariatric surgery for treating obesity.
  • Advantageously, the detection means [0034] 6 of device 1 is intended to measure the impedance of abdominal fat tissues, and the processing means 7 is intended to indicate the extent of intra-abdominal fat.
  • Preferably, the detection means [0035] 6 is intended to detect the tension (potential different) between abdominal tissues when the same are crossed by a predetermined current.
  • The operation of the device for controlling the extent of intra-abdominal fat according to the invention is evident from what described and illustrated, and in particular, it substantially is as follows. [0036]
  • The operation is based on the principle that biological tissues exhibit a certain impedance upon the passage of electrical current, which varies according to the extent of the different proportions between lean mass, adipose tissue and liquids of which they are composed. [0037]
  • Thus, when [0038] stimulator 2 generates an electrical signal, it circulates in the electro-catheter 5 up to the first pole 3, crosses the tissue containing also the adipose component (of course predominant in obese individuals) and reaches the second pole 4.
  • During the queries of the signal generator or pacemaker (generally on a monthly, three-monthly or annual basis), also a single-pole signal is generated to test the tissue impedance. [0039]
  • A dedicated software stores the obtained values to the signal generator or pacemaker memory, and provides a graph on a fixed number of months. [0040]
  • The query-programming of the signal generator or pacemaker occurs through electromagnetic pulses provided by an outside WAND. [0041]
  • The detection means [0042] 6 detects the difference of potential at the end of the adipose tissue and thus, based on the known Ohm law (V=R×i, where V is the different of potential at the ends of the intra-abdominal adipose tissue, R is the impedance of body tissues, and i is the current passing through the biological tissues comprised between the two poles), the impedance R W of the intra-abdominal adipose layer is obtained.
  • From the impedance value R the processing means is capable of obtaining the extent of endo-abdominal fat since, as known, the biological tissue exhibits a given impedance upon the passage of an electrical current, which varies according to the different extent of fat contained therein. [0043]
  • The present finding also relates to a procedure for controlling the extent of intra-abdominal fat. [0044]
  • The procedure according to the finding consists in measuring the impedance of abdominal adipose tissues and hence, obtaining the extent of intra-abdominal fat. [0045]
  • Impedance is measured by making a predetermined current pass through the abdominal tissues and measuring the tension between abdominal tissues. [0046]
  • Preferably, impedance is measured between the stomach surface and the abdomen wall. [0047]
  • Moreover, the procedure provides for the preliminary application of an electrical signal generator [0048] 2 (pacemaker) in super-fascial position.
  • In the practice, it has been proved that the device and procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming according to the invention, are especially advantageous since they allow tracing a curve of endo-abdominal fat loss, which has a considerable prognostic importance on the patient's health. [0049]
  • The device and procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming thus conceived can be subject to several variants and changes, all falling within the scope of the invention idea; moreover, all details can be replaced with other technically equivalent elements. [0050]
  • In the practice, the materials used as well as the sizes, can be of any type according to the needs and to the state of the art. [0051]

Claims (12)

1. Device (1) for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming, characterised in that it comprises at least one electrical signal generator (2) connected to at least one first pole (3), associable to the stomach surface, and to a second pole (4), associable to the abdominal wall, said poles (3, 4) being connected to detection means (6) and processing means (7) of said electrical signals intended to provide an indicative signal of the extent of intra-abdominal fat.
2. Device (1) according to claim 1, characterised in that said electrical signal generator (2) is intended to generate pulse signals.
3. Device (1) according to one or more of the previous claims, characterised in that said second pole (4) comprises at least one portion of said electrical signal generator (2).
4. Device (1) according to one or more of the previous claims, characterised in that said first pole (3) is component of an electro-catheter.
5. Device (1) according to one or more of the previous claims, characterised in that said second pole (4) comprises an outside detector, and in that said first pole (3) comprises at least one electrode.
6. Device (1) according to one or more of the previous claims, characterised in that said detection means (6) is intended to measure the impedance of abdominal adipose tissues, and in that said processing means (7) is intended to indicate he extent of intra-abdominal fat.
7. Device (1) according to one or more of the previous claims, characterised in that said detection means (7) is intended to measure the tension (potential different) between said abdominal tissues when the same are crossed by a predetermined current.
8. Procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming, characterised in that the impedance of abdominal adipose tissues is measured and hence, the extent of intra-abdominal fat is obtained.
9. Procedure according to claim 8, characterised in that said impedance is measured by making a predetermined current pass through the abdominal tissues and measuring the tension between said abdominal tissues.
10. Procedure according to claim 8 or 9, characterised in that impedance is measured between the stomach surface and the abdominal wall.
11. Procedure according to one or more of claims 8 and following ones, characterised in that it provides for the application of an electrical signal generator (2) in super-fascial position.
12. Device and procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming as described and claimed.
US10/112,600 2001-03-30 2002-03-28 Device and procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming Expired - Fee Related US6889076B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI000684A ITMI20010684A1 (en) 2001-03-30 2001-03-30 DEVICE AND PROCEDURE FOR CHECKING THE ENTITY OF THE INTRA-ABDOMINAL FAT
ITMI2001A000684 2001-03-30

Publications (2)

Publication Number Publication Date
US20020156393A1 true US20020156393A1 (en) 2002-10-24
US6889076B2 US6889076B2 (en) 2005-05-03

Family

ID=11447410

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/112,600 Expired - Fee Related US6889076B2 (en) 2001-03-30 2002-03-28 Device and procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming

Country Status (6)

Country Link
US (1) US6889076B2 (en)
EP (1) EP1245186B1 (en)
AT (1) ATE304811T1 (en)
DE (1) DE60206206T2 (en)
ES (1) ES2249507T3 (en)
IT (1) ITMI20010684A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100100146A1 (en) * 2006-09-25 2010-04-22 Andreas Blomqvist Medical device comprising an impedance measurement means to measure visceral fat

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6587719B1 (en) 1999-07-01 2003-07-01 Cyberonics, Inc. Treatment of obesity by bilateral vagus nerve stimulation
US6540789B1 (en) 2000-06-15 2003-04-01 Scimed Life Systems, Inc. Method for treating morbid obesity
US6609025B2 (en) 2001-01-02 2003-08-19 Cyberonics, Inc. Treatment of obesity by bilateral sub-diaphragmatic nerve stimulation
US7463928B2 (en) * 2003-04-25 2008-12-09 Medtronic, Inc. Identifying combinations of electrodes for neurostimulation therapy
US7194301B2 (en) 2003-10-06 2007-03-20 Transneuronic, Inc. Method for screening and treating patients at risk of medical disorders
US7899540B2 (en) * 2005-04-29 2011-03-01 Cyberonics, Inc. Noninvasively adjustable gastric band
US7835796B2 (en) * 2005-04-29 2010-11-16 Cyberonics, Inc. Weight loss method and device
US7310557B2 (en) * 2005-04-29 2007-12-18 Maschino Steven E Identification of electrodes for nerve stimulation in the treatment of eating disorders
US7706874B2 (en) 2005-07-28 2010-04-27 Cyberonics, Inc. Stimulating cranial nerve to treat disorders associated with the thyroid gland
US8660647B2 (en) * 2005-07-28 2014-02-25 Cyberonics, Inc. Stimulating cranial nerve to treat pulmonary disorder
US7856273B2 (en) 2005-07-28 2010-12-21 Cyberonics, Inc. Autonomic nerve stimulation to treat a gastrointestinal disorder
US7620455B2 (en) 2005-10-25 2009-11-17 Cyberonics, Inc. Cranial nerve stimulation to treat eating disorders
US7957796B2 (en) 2005-10-28 2011-06-07 Cyberonics, Inc. Using physiological sensor data with an implantable medical device
US7657310B2 (en) 2006-01-26 2010-02-02 Cyberonics, Inc. Treatment of reproductive endocrine disorders by vagus nerve stimulation
US7801601B2 (en) 2006-01-27 2010-09-21 Cyberonics, Inc. Controlling neuromodulation using stimulus modalities
US8712539B2 (en) 2006-04-12 2014-04-29 Medtronic, Inc. Rule-based stimulation program search
US20070255154A1 (en) * 2006-04-28 2007-11-01 Medtronic, Inc. Activity level feedback for managing obesity
US7558629B2 (en) * 2006-04-28 2009-07-07 Medtronic, Inc. Energy balance therapy for obesity management
US8126538B2 (en) * 2006-06-06 2012-02-28 Cardiac Pacemakers, Inc. Method and apparatus for introducing endolymphatic instrumentation
US20070282376A1 (en) * 2006-06-06 2007-12-06 Shuros Allan C Method and apparatus for neural stimulation via the lymphatic system
US7894906B2 (en) * 2006-06-06 2011-02-22 Cardiac Pacemakers, Inc. Amelioration of chronic pain by endolymphatic stimulation
US7734341B2 (en) * 2006-06-06 2010-06-08 Cardiac Pacemakers, Inc. Method and apparatus for gastrointestinal stimulation via the lymphatic system
US8905999B2 (en) * 2006-09-01 2014-12-09 Cardiac Pacemakers, Inc. Method and apparatus for endolymphatic drug delivery
US7706875B2 (en) * 2007-01-25 2010-04-27 Cyberonics, Inc. Modulation of drug effects by vagus nerve stimulation
CA2714754A1 (en) * 2007-02-13 2008-08-21 Virender K. Sharma Method and apparatus for electrical stimulation of the pancreatico-biliary system
US7962214B2 (en) 2007-04-26 2011-06-14 Cyberonics, Inc. Non-surgical device and methods for trans-esophageal vagus nerve stimulation
US7869884B2 (en) 2007-04-26 2011-01-11 Cyberonics, Inc. Non-surgical device and methods for trans-esophageal vagus nerve stimulation
US7904175B2 (en) 2007-04-26 2011-03-08 Cyberonics, Inc. Trans-esophageal vagus nerve stimulation
US20080294228A1 (en) * 2007-05-23 2008-11-27 Cardiac Pacemakers Method and device for controlled stimulation of lymphatic flow
WO2010042686A1 (en) 2008-10-09 2010-04-15 Sharma Virender K Method and apparatus for stimulating the vascular system
US10603489B2 (en) 2008-10-09 2020-03-31 Virender K. Sharma Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage
US8755888B2 (en) 2012-10-17 2014-06-17 Melcap Systems Ltd. Gastrointestinal system

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5335667A (en) * 1992-11-20 1994-08-09 University Of Utah Research Foundation Method and apparatus for determining body composition using bioelectrical impedance
US5449000A (en) * 1988-05-24 1995-09-12 Abc Development System for body impedance data acquisition utilizing segmental impedance & multiple frequency impedance
US5833625A (en) * 1993-10-21 1998-11-10 Synectics Medical Ab Ambulatory reflux monitoring system
US6285898B1 (en) * 1993-07-20 2001-09-04 Biosense, Inc. Cardiac electromechanics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4852580A (en) * 1986-09-17 1989-08-01 Axiom Medical, Inc. Catheter for measuring bioimpedance
IT1260485B (en) * 1992-05-29 1996-04-09 PROCEDURE AND DEVICE FOR THE TREATMENT OF THE OBESITY OF A PATIENT
NL9300028A (en) * 1993-01-07 1994-08-01 Academisch Ziekenhuis Utrecht Method for measuring the electrical impedance in blood vessels and catheterization system using a catheter to carry out that method.
TW514510B (en) * 1999-06-11 2002-12-21 Tanita Seisakusho Kk Method and apparatus for measuring distribution of body fat

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449000A (en) * 1988-05-24 1995-09-12 Abc Development System for body impedance data acquisition utilizing segmental impedance & multiple frequency impedance
US5335667A (en) * 1992-11-20 1994-08-09 University Of Utah Research Foundation Method and apparatus for determining body composition using bioelectrical impedance
US6285898B1 (en) * 1993-07-20 2001-09-04 Biosense, Inc. Cardiac electromechanics
US5833625A (en) * 1993-10-21 1998-11-10 Synectics Medical Ab Ambulatory reflux monitoring system

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100100146A1 (en) * 2006-09-25 2010-04-22 Andreas Blomqvist Medical device comprising an impedance measurement means to measure visceral fat
US8761871B2 (en) 2006-09-25 2014-06-24 St. Jude Medical, AB Medical device comprising an impedance measurement means to measure visceral fat

Also Published As

Publication number Publication date
ES2249507T3 (en) 2006-04-01
ATE304811T1 (en) 2005-10-15
EP1245186A1 (en) 2002-10-02
US6889076B2 (en) 2005-05-03
ITMI20010684A1 (en) 2002-09-30
DE60206206T2 (en) 2006-06-22
EP1245186B1 (en) 2005-09-21
DE60206206D1 (en) 2005-10-27
ITMI20010684A0 (en) 2001-03-30

Similar Documents

Publication Publication Date Title
US20020156393A1 (en) Device and procedure for controlling the extent of intra-abdominal fat in the monitoring of an individual's slimming
US10716489B2 (en) Determining biological tissue type
US6723049B2 (en) Apparatus for tissue type recognition using multiple measurement techniques
DE60219905T2 (en) SYSTEM AND METHOD FOR DETERMINING THE DISSOLUTION OF AN IMPLANTABLE MEDICAL DEVICE
US4819648A (en) Non-invasive electromagnetic technique for monitoring time-trends of physiological changes at a particular location in the brain
US5480420A (en) Resorbable temporary medical electrode device
US5339827A (en) Acupuncture system and method
US20180177431A1 (en) Implantable monitoring device
WO2003092495A1 (en) Intracavitary impedance measuring probe
RU2112416C1 (en) Method for checking of tissue or organ condition after operation and device for its realization
JP2005512663A (en) Moisture probe
EP0648087A1 (en) Ablation catheter positioning system
JP2024116299A (en) DEVICE FOR INTRAOPERATIVE NERVOMONIORATION OF THE NERVE OF THE PELVIC REGION OF A PATIENT - Patent application
US10912482B2 (en) Method for determining at least one type and/or condition of cells and system
Johns et al. Variability in effective radiating area and output power of new ultrasound transducers at 3 MHz
US20150328450A1 (en) Wound treatment
WO2010061297A1 (en) Methods of diagnosis and treating wounds and screening for electrical markers for wounds prognosis
WO2019228887A1 (en) Systems and methods for assessing a physiological property of a biological tissue based on its microwave transmission properties
RU2376933C1 (en) System of electroimpedance oncology diagnostics
US20220338813A1 (en) Implantable electronic sensing system for measuring and monitoring medical parameters
US20170231548A1 (en) System and method for bladder transducer placement
WO2004037082A1 (en) Anatomical sensor

Legal Events

Date Code Title Description
AS Assignment

Owner name: TRANSNEURONIX, INC., NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CIGAINA, VALERIO;REEL/FRAME:014962/0856

Effective date: 20040802

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20170503

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载